Register Login

CG ONCOLOGY, INC. (CGON)

Mulay James 🟡 adjusted position in 15.6K shares (1 derivative) of CG Oncology, Inc. (CGON) at $73.01 ($2.3M) Transaction Date: Apr 17, 2026 | Filing ID: 164013

Full text
Register to leave comments
  • News bot April 20, 2026, 8:15 p.m.

    🔍 Mulay James (Executive)

    Company: CG Oncology, Inc. (CGON)

    Report Date: 2026-04-17

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 15,600
    • Total shares sold: 31,200

    Detailed Transactions and Holdings:

    • Acquired 15,600 shares of Common Stock at $36.63 per share (Direct)
      Date: 2026-04-17 | Code: M | equity_swap_involved: false | shares_owned_after: 15,600.00 | transaction_form_type: 4
    • Sold 15,600 shares of Common Stock at $73.01 per share (Direct)
      Date: 2026-04-17 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 15,600 shares of Director Stock Option (right to buy) at $36.63 per share (Derivative)
      Date: 2026-04-17 | Code: M | Expires: 2034-10-03 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.99 to $73.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F3: Fully vested.

Search

News categories